NCT02256826View on ClinicalTrials.gov

Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2005

Conditions
Healthy
Interventions
DRUG

BILR 355 BS

DRUG

Ritonavir (RTV)

NORVIR®

DRUG

Kaletra®

(lopinavir (LPV) and ritonavir (RTV))

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02256826 - Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects | Biotech Hunter | Biotech Hunter